2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
54
Neoplasms
38
Lung Neoplasms
25
Colorectal Neoplasms
24
Prostatic Neoplasms
17
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Pancreatic Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Hematologic Neoplasms
9
Anxiety Disorders
9
Urinary Bladder Neoplasms
8
Obesity
8
Melanoma
8
Lymphoma
8
Depression
8
Ovarian Neoplasms
7
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Sarcoma
5
Papillomavirus Infections
5
Pain
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Interventions
Surveys and Questionnaires
3
pazopanib
2
Sunitinib
2
Sorafenib
2
Bevacizumab
2
Radiation Dose Hypofractionation
1
Quality Indicators, Health Care
1
Patient Transfer
1
Patient Reported Outcome Measures
1
Methods
1
Medical Records
1
Mass Screening
1
Immunization, Secondary
1
Early Intervention, Educational
1
Data Collection
1
Counseling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Financial Stress
×
Methods
×
Clear all
NCT05939440
2025-06-05
P-COC
University of Alabama at Birmingham
Phase NA
Completed
60 enrolled